Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METEOR-China: Rosuvastatin for CIMT in Chinese Adults
NCT02546323Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2015
- Primary completion
- Jan 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin in atherosclerosis, sponsored by AstraZeneca. Started Sep 2015; status: completed.
02
Drugs
rosuvastatin
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT02546323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02546323.